Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation

Cancer Research

Volumn 71, Issue 5, 2011, Pages 1669-1679

  Risques, Rosa Ana ^a   Lai, Lisa A ^b   Himmetoglu, Cigdem ^a   Ebaee, Anoosheh ^a   Li, Lin ^c   Feng, Ziding ^c   Bronner, Mary P ^e   Al Lahham, Bassel ^f   Kowdley, Kris V ^d   Lindor, Keith D ^g   Rabinovitch, Peter S ^a,c   Brentnall, Teresa A ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d VIRGINIA MASON MEDICAL CENTER   (United States)

^e Cleveland Clinic ^*  (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; PROTEIN P53; TELOMERASE;

ADULT; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA DAMAGE; DYSPLASIA; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC PARAMETERS; HIGH GRADE DYSPLASIA; HUMAN; HUMAN TISSUE; INFLAMMATION; INTESTINE CELL; LAMINA PROPRIA; LEUKOCYTE; LOW GRADE DYSPLASIA; MOLECULAR MECHANICS; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENESCENCE; TELOMERE SHORTENING; TUMOR GROWTH; ULCERATIVE COLITIS;

ADULT; CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 79952220119     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-1966     Document Type: Article

References (39)

1. Brentnall TA. Molecular underpinnings of cancer in ulcerative colitis. Curr Opin Gastroenterol 2003;19:64-8. (Pubitemid 36005864)
2. Risques RA, Rabinovitch PS, Brentnall TA. Cancer surveillance in inflammatory bowel disease: new molecular approaches. Curr Opin Gastroenterol 2006;22:382-90. (Pubitemid 44090193)
3. Chai H, Brown RE. Field effect in cancer-an update. Ann Clin Lab Sci 2009;39:331-7.
4. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994; 107:369-78. (Pubitemid 24233310)
5. Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, et al. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 1992; 103:1602-10.
6. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 2000;60:3333-7. (Pubitemid 30482141)
7. Willenbucher RF, Aust DE, Chang CG, Zelman SJ, Ferrell LD, Moore DH II, et al. Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am J Pathol 1999; 154:1825-30. (Pubitemid 29262864)
8. Rabinovitch PS, Dziadon S, Brentnall TA, Emond MJ, Crispin DA, Haggitt RC, et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999;59: 5148-53. (Pubitemid 29503975)
9. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002;27:339-44.
10. Risques RA, Lai LA, Brentnall TA, Li L, Feng Z, Gallaher J, et al. Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology 2008; 135:410-8.
11. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002;32:280-4.
12. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-9. (Pubitemid 38182302)
13. Cheng Y, Desreumaux P. 5-Aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease. World J Gastroenterol 2005;11: 309-14. (Pubitemid 40125228)
14. O'Connor PM, Lapointe TK, Beck PL, Buret AG. Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease. Inflamm Bowel Dis 2010;16:1411-20.
15. Roessner A, Kuester D, Malfertheiner P, Schneider-Stock R. Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathol Res Pract 2008;204:511-24.
16. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005;37:961-76. (Pubitemid 40311739)
17. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, et al. A DNA damage checkpoint response in telomere- initiated senescence. Nature 2003;426:194-8.
18. Collado M, Serrano M. The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 2006;6:472-6.
19. Qian Y, Zhang J, Yan B, Chen X. DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence. J Biol Chem 2008;283: 2896-905.
20. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010;5:99-118.
21. Fumagalli M, d'Adda di Fagagna F. SASPense and DDRama in cancer and ageing. Nat Cell Biol 2009;11:921-3.
22. Risques RA, Vaughan TL, Li X, Odze RD, Blount PL, Ayub K, et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007;16:2649-55. (Pubitemid 351210548)
23. Ohuchida K, Mizumoto K, Ogura Y, Ishikawa N, Nagai E, Yamaguchi K, et al. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer. Clin Cancer Res 2005;11:2285-92. (Pubitemid 40490188)
24. Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 2004;14:501-13. (Pubitemid 38648803)
25. O'Sullivan J, Risques RA, Mandelson MT, Chen L, Brentnall TA, Bronner MP, et al. Telomere length in the colon declines with age: a relation to colorectal cancer?Cancer Epidemiol Biomarkers Prev 2006;15:573-7.
26. O'Sullivan JN, Finley JC, Risques RA, Shen WT, Gollahon KA, Moskovitz AH, et al. Telomere length assessment in tissue sections by quantitative FISH: image analysis algorithms. Cytometry 2004;58A: 120-31. (Pubitemid 38509173)
27. Wong NA, Mayer NJ, MacKell S, Gilmour HM, Harrison DJ. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia. Histopathology 2000;37:108-14. (Pubitemid 30608507)
28. Yoshida T, Matsumoto N, Mikami T, Okayasu I. Upregulation of p16 (INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours. Br J Cancer 2004;91:1081-8. (Pubitemid 39336246)
29. Artandi SE, Attardi LD. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. Biochem Biophys Res Commun 2005;331:881-90. (Pubitemid 40615519)
30. Smogorzewska A, de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J 2002;21:4338-48.
31. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001;61:3573-7. (Pubitemid 32694963)
32. Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A. Pathways connecting inflammation and cancer. Curr Opin Genet Dev 2008; 18:3-10. (Pubitemid 351694444)
33. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 2010;16:238-46.
34. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7-17.
35. Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003;24:353-62. (Pubitemid 36432628)
36. Indran IR, Hande MP, Pervaiz S. Tumor cell redox state and mitochondria at the center of the non-canonical activity of telomerase reverse transcriptase. Mol Aspects Med 2010;31:21-8.
37. Saretzki G. Telomerase, mitochondria and oxidative stress. Exp Gerontol 2009;44:485-92.
38. Matsumoto N, Yoshida T, Okayasu I. High epithelial and stromal genetic instability of chromosome 17 in ulcerative colitis-associated carcinogenesis. Cancer Res 2003;63:6158-61. (Pubitemid 37255156)
39. Yagishita H, Yoshida T, Ishiguro K, Numata Y, Okayasu I. Epithelial and stromal genetic instability linked to tumor suppressor genes in ulcerative colitis-associated tumorigenesis. Scand J Gastroenterol 2008;43:559-66. (Pubitemid 351536049)